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Chapter 1 - Introduction
Background and Significance
Hypertension (HTN) [systolic blood pressure (SBP) ≥140 mmHg and/or diastolic
blood pressure (DBP) ≥90 mmHg] is a major public health concern. Over one billion
adults worldwide have HTN and approximately 7.1 million deaths per year are attributed
to HTN (1). In the United States (US) approximately 74.5 million (25%) adults have
HTN and an additional 86 million (28%) have preHTN (SBP 120-139 mmHg and/or
DBP 80-89 mmHg) (1). Higher resting blood pressure (BP) increases the risk of
developing HTN and cardiovascular disease (CVD). Over a four year period, 19% of
individuals with preHTN will develop HTN (2). By 2020, 1.56 billion adults worldwide
will have HTN (3).
Resting BP is a major CVD risk factor. Beginning at a BP of 115/75 mmHg, an
increase in SBP of 20 mmHg or DBP of 10 mmHg doubles the risk of developing CVD
(4). Additionally, HTN is a contributor to the metabolic syndrome (MetS) (5). The Adult
Treatment Panel III (ATP III) defines the MetS as having three or more of the following
CVD risk factors simultaneously: fasting triglycerides ≥150 mg/dL, BP ≥ 130/85 mmHg,
fasting glucose ≥ 100 mg/dL, BP ≥ 130/85 mmHg, waist circumference for men ≥102 cm
and women ≥88 cm, and fasting high density lipoprotein <40 mg/dL for men and <50
mg/dL for women (6). Individuals with the MetS have increased prevalence of HTN
(49%) when compared to individuals who do not have the MetS (40%) (7) and
experience a two-fold increase in CVD risk (8). Furthermore, 71.6% of all individuals
with HTN will develop the MetS (9).
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The role of lifestyle modifications, such as engaging in exercise, is critical for the
prevention, treatment and control of HTN. Aerobic exercise lowers resting BP 5 to 7
mmHg, while resistance exercise (used as a supplement to aerobic exercise) reduces BP 2
to 3 mmHg among those individuals with HTN (10). The American College of Sports
Medicine [(ACSM) (10)] therefore recommends individuals with HTN to engage in
moderate intensity, aerobic exercise on most days of the wk for 30-60 min·d-1
supplemented by resistance exercise 2-3 d·wk-1.
Although exercise is recommended as an initial lifestyle therapy to lower BP,
over 80% of the US adult population does not meet the recommended amount of daily
physical activity (3). Individuals with HTN are less physically active than individuals
without HTN (11). Physical inactivity is a major public health concern that increases the
risk of mortality by 20-30% when compared to those individuals who meet the physical
activity requirements per week (3). Physical inactivity may also contribute to HTN,
higher rates of type 2 diabetes mellitus, dyslipidemia, and the risk of developing CVD
which can further increase morbidity and/or mortality. In 2010, physical inactivity
contributed to 9% of all-cause mortality in the US adult population (12).
Aerobic exercise is reported to lower resting BP among those with HTN.
However, the BP response to exercise is quite variable (13). Indeed, 25% of those with
HTN do not lower their BP following aerobic exercise training (14). One explanation for
this variability is the law of initial values such that individuals with the highest resting
baseline BP experience the greatest reductions (15). Further, Bouchard et al. (13)
examined 481 healthy, young sedentary (17-29 yr) men and women with normal to
preHTN BP during submaximal cycle exercise training. Bouchard and colleagues found,
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the mean SBP response to exercise decreased an average of 8.2 mmHg however; the
standard deviation ±11.8 mmHg exceeded the mean SBP change across the total sample.
In conclusion, there is considerable intra- and inter- variability in the BP response to
exercise training.
The antihypertensive effects of aerobic exercise training occur rapidly within
three sessions, persist with continued training, and diminish to pre-training levels within
2 wk after training has ceased (16,17). Meredith et al. (16) found healthy individuals with
normal BP reduced SBP and DBP 5 mmHg after one month of cycling at 60-70%
maximal oxygen consumption (VO2max) for 40 min, three times per wk. However, the
magnitude of the BP reduction was maximized within the first three sessions. After the
cessation of exercise training, BP regressed back to resting values within 2 wk. Murray et
al. (17) observed similar results with healthy, young men who performed 30 min (60%
VO2peak) bouts of aerobic exercise on a cycle ergometer, three to four times per wk.
Within the first four exercise training sessions BP reductions were seen, SBP decreased
11 mmHg and DBP 9 mmHg. After one wk of exercise cessation, BP regressed back to
resting levels (SBP increased 5 mmHg and DBP 3 mmHg). These studies show that
within one wk of the onset or cessation of aerobic exercise training there is a rapid BP
reduction and disappearance respectively in response to exercise training.
Statement of the Problem
Exercise is recommended as a non-pharmacological therapy for the prevention,
treatment and control of HTN. Despite the consensus that endurance exercise lowers BP
5-7 mmHg among those with HTN, 25% of these individuals do not reduce their BP
following endurance exercise for reasons that are unclear (14). Shortly after exercise
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training has ceased, within one wk, BP increases during detraining and returns to preexercise training values (16,17). However, the relation between the BP response during
exercise training and a detraining period has yet to be examined in the same group of
people. Clinically, it is important for physicians and exercise specialists to identify which
individuals respond and do not respond to exercise training as an antihypertensive
therapy. Additionally, to examine and identify baseline predictors of individuals at risk
with adverse response to exercise training, further offering an alternative approach to
modifying and executing a more effective exercise prescription as an antihypertensive
therapy.
Therefore, the purpose of this study was to examine the BP response after 6
months of exercise training followed by a 2 wk detraining period among middle-aged,
sedentary adults with preHTN and mild to moderate dyslipidemia from the clinical trial,
Studies of a Targeted Risk Reduction through Defined Exercise (STRRIDE-AT/RT)
(1R01HL57354; 2003-2008; NCT00275145) (18).
Specific Aims
The primary aim of this sub-study is to investigate the BP response before and
after 6 months of exercise training and 2 wk of detraining among subjects from
STRRIDE-AT/RT with preHTN and mild to moderate dyslipidemia. Secondly, this substudy intended to explore clinical characteristics that may modulate the BP response to
exercise training and detraining. We hypothesize middle-aged adults with preHTN and
mild to moderate dyslipidemia will decrease their BP with 6 months of exercise training.
Furthermore, we hypothesize that the same group of individuals will increase their BP
with exercise detraining.
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Chapter 2 - Review of Literature
Introduction
In the United States one in three adults have HTN (1). HTN, SBP ≥140 and/or
DBP ≥90 mmHg and/or taking antihypertensive medication, is a significant public health
problem that continues to grow in prevalence. Over a four-year period, 19% of
individuals with preHTN developed HTN (2). Resting BP is a major independent risk
factor for CVD. Beginning at a BP of 115/75 mmHg, an increase in SBP of 20 mmHg or
10 mmHg in DBP doubles the risk of developing CVD (4). Therefore, the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
(JNC 7) recommends exercise as lifestyle therapy to prevent, treat, and control HTN (19).
Although exercise is recommended as the initial lifestyle therapy to lower BP,
over 80% of the United States adult population does not meet the recommended daily
physical activity requirements (3). Further, individuals who are less physically active and
less fit than those who meet the physical activity recommendations have a 30-50%
greater risk for having HTN (1). Therefore, it is important for individuals to engage in the
recommended amount of physical activity/day to lower BP and prevent the progression of
preHTN to HTN.
The Antihypertensive Effects of Aerobic Exercise
The JNC 7 recommends exercise as a lifestyle therapy for the prevention,
treatment and control of HTN. Those with HTN who engage in aerobic exercise exhibit a
BP reduction of 5 to 7 mmHg (10). Further, the ACSM recommends moderate intensity
aerobic exercise performed on most days of the week for 30-60 min·d-1 to lower BP.
Fagard (20) meta-analyzed the influence of exercise characteristics and the BP response
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to dynamic aerobic or endurance exercise in healthy individuals with normal BP and
individuals with HTN. The results from the meta analysis concluded aerobic training
3 d·wk-1 for 40 min·d-1 at 65% VO2max reduces BP on average 3/2 mmHg in individuals
with optimal BP, however greater reductions were seen among individuals with HTN; 7
mmHg SBP and 6 mmHg DBP (20). Therefore, training 3-5 d·wk-1 for 30-60 min·d-1 at
40-50% VO2max exhibits an effective mode of exercise to reduce BP and supports the
ACSM guidelines for exercise. Mughal et al. (21) looked at the changes in BP with
aerobic exercise over a 12 wk period in 27 men (39 yr) with HTN (143/91 mmHg).
Subjects engaged in an exercise training protocol walking at 50% VO2max for 30 min·d-1,
3-5 d·wk-1. The results showed BP reductions of 5.7 mmHg SBP and 1.4 mmHg DBP.
Although these reductions are slightly less than ACSM, these findings indicate that
walking, a low cost activity can still reduce BP in individuals with HTN.
The prevalence of HTN increases with age with higher DBP values until the age
of 55 at which values slowly decline, while SBP values continue to increases with age
(22). Therefore it is important and beneficial to engage in exercise training for the
prevention, treatment, and management of HTN. As previously discussed the literature
indicates aerobic exercise is an effective non-pharmacological treatment to prevent,
manage and treat HTN. BP reductions occur over a short period of time within 1-2 wk of
the onset of aerobic exercise training and persist with continued exercise (16,17). Further,
BP reductions are exhibited in individuals with normal BP and in individuals with HTN
regardless of their pre exercise (resting) BP status. However, the antihypertensive effects
of aerobic exercise training appear to be more pronounced among individuals with
preHTN or HTN.
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Variability to BP Response to Exercise Training
Although aerobic exercise has shown to be an effective antihypertensive strategy,
the magnitude and duration of these BP reductions vary widely across studies. Bouchard
and Rankinen (13) noted high levels of heterogeneity in the BP response to different
exercise programs and modalities (aerobic, resistance, and combined aerobic and
resistance exercise) among individuals with HTN. SBP was taken during an acute bout of
exercise, cycling at 50 Watts. These researchers from the HERITAGE family study (13)
reported that 723 sedentary men and women aged 17-29 yr had a BP average overall
reduction of 8.2 ±11.8 mmHg. However, individuals with higher resting mean SBP
reduced overall BP 13.4 ± 12.2 mmHg and individuals with lower resting mean SBP
resulted in a lesser BP reduction of 3±8.8 mmHg. In addition, the standard deviation of
the overall reduction exceeded the average mean change (8.2 ±11.8 mmHg), which
demonstrated the wide variability in the BP response to exercise training from individual
to individual. The study concluded that there is evidence that there is considerable
heterogeneity in the response of physiological indicators of risk factors to regular
physical activity and pretraining levels of SBP which has an impact on determining the
response to exercise training (23).
The Antihypertensive Effects of Resistance Exercise
As a supplement to aerobic exercise, the ACSM (2004) recommends individuals
with HTN perform resistance exercise 2-3 d·wk-1 of at least one set of 8-12 repetitions
[60-80% of 1 repetition maximum (RM)] (24). There is a large body of evidence to
support the antihypertensive effects of aerobic exercise on resting BP. However,
resistance training has been deemed safe for individuals with HTN (25) with average
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reductions of 3 mmHg post training when performed in accordance with the current
ACSM recommendations (24). These reductions exhibited with resistance training are
less than those with aerobic training therefore resistance training is recommended as a
supplement to aerobic training.
Resistance training has positive health effects by increasing strength and by
decreasing resting BP. Sallinen et al. (26) examined 43 men (58 yr) with HTN
(130.1/82.4 mmHg) but otherwise healthy over 42 wk. Individuals were randomized to a
strength training group (n=20) or a control group (n=19). Individuals in the strength
group performed 14 exercise on standard exercise machines completing 3-6 sets of
pyramid repetitions (10-15, 8-10, 5-8) at 40-80% 1 RM (intensity progressed), 3 d·wk-1.
At the end of the 21 wk SBP and DBP were reduced 4 mmHg with no further reductions
seen in SBP after 42 wk however DBP did statistically reduce when compared to the
control group. The findings of the present study are consistent with previous literature
and demonstrate that strength training can be helpful for individuals with preHTN to
reduce BP safely and effectively.
Cornelissen et al. (27) examined the frequency, intensity, time, and type (FITT)
principle in a Meta analysis. The authors concluded that training performed on weight
machines 3 d·wk-1 for 16 weeks, 3 sets of 8 exercises of 76% 1 RM exhibited an overall
decrease in BP in individuals with preHTN (3.9 in SBP and 3.6 mmHg in DBP). Further
concluding, an established resistance training regimen could be used as a nonpharmacological aid to prevent, treat, and control high BP.
In summary, as the previous literature shows resistance training if done in
accordance to ACSM guidelines is safe and can help reduce BP in individuals with
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preHTN and HTN. Therefore, resistance training as a supplement to aerobic training can
be used as a non-pharmacological aid to prevent, treat, and control high BP.
The Antihypertensive Effects of Concurrent Aerobic and Resistance Exercise
There is limited literature examining the BP lowering effects of concurrent
aerobic and resistance training regimen. Keese at el. (28) examined middle-aged men
(20-30 yr) with optimal BP (111/73 mmHg) performing four acute experimental visits.
The protocol consisted of one control session of seated rest and three acute exercise
sessions of different modalities; aerobic exercise at 65% VO2peak on a cycle ergometer for
60 min, resistance training of 3 sets of 8 exercises performed at 80% of 1 RM, and
aerobic plus resistance training session with similar protocol of the aerobic and resistance
sessions. Aerobic exercise, acute training, alone reduced SBP 6.3±1.3 mmHg and DBP
1.8±1.0 mmHg, while resistance training reduced BP 4.1±3.0/ 1.8±1.1 mmHg,
respectively.
Shaw et al. (29) examined 37 sedentary adult males (25 yr) that performed aerobic
or concurrent aerobic and resistance training for 16 weeks, 3 d·wk-1 for 60 min·d-1.
Subjects were divided into one of three groups; control group, aerobic (60% HRmax), or
an aerobic (60% of maximum heart rate) and resistance-training group combined (8
exercises of 2 sets of 15 repetitions at 60% 1 RM). Both aerobic and concurrent exercise
showed effective and favorable improvements in SBP. However, BP reductions with the
aerobic group exhibited smaller reductions of 3.9±3.8mmHg while the concurrent group
elicited BP reductions of 9.8±1.4 mmHg. The results demonstrate that concurrent training
can help reduce BP the same as aerobic training alone taking note that concurrent training
only did half of the aerobic training as the aerobic training only group.
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Similarly, Wallace et al. (30) examined 16 sedentary men (41 yr) with
hyperinsulemia in addition to two other components of the MetS that performed
endurance or a concurrent endurance and resistance training group for 14 wk. Subjects
randomized into endurance group (60-70% heart rate reserve) engaged in walking on the
treadmill or the cycle ergometer for 30 min·d-1, the concurrent group followed the same
protocol as the aerobic group but added resistance training (8 exercises of 4 sets of 8-12
sets at 75% 1 RM). After the exercise program concluded, SBP reductions were greater in
the concurrent group (14.6±5.5 mmHg) than the endurance training group (8.3±6.8
mmHg) indicating adding resistance training to endurance training produce greater SBP
reductions.
In summary aerobic and resistance exercise combined has shown to lower BP
similar to aerobic or resistance training in individuals with preHTN. Additionally,
concurrent training can be as effective in an antihypertensive therapy than aerobic or
resistance exercise done in isolation.
The Blood Pressure Response to Detraining
The effects of detraining on BP have not been extensively researched. Meredith
et al. (16) examined the effects of detraining following four weeks of exercise training of
3 d·wk-1 at 60-70% VO2max for 40 min·d-1 on a bicycle ergometer. Ten sedentary men (5)
and women (5), with normal BP and otherwise healthy adults (age 21 yr), decreased
resting BP by 8/5 mmHg following one month of exercise training. Reductions in BP
were seen within the first three visits or one week of the onset of exercise training and
were fully established by the fourth training visit with no further reductions in BP over
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the next month. After the cessation of exercise, BP returned to baseline values within 2
weeks signifying that BP reductions occur and disappear rapidly.
Murray et al. (17) examined the effects of aerobic exercise training, cycle
ergometer 30 min·d-1 at 60% VO2peak among 17 young (22 yr) men with preHTN. After
one week, or four sessions, from the onset of exercise, SBP was lowered by 10±1 mmHg
and DBP by 8±7 mmHg with no further reductions occurring after the second week.
Following the cessation of exercise, resting SBP not only returned back to pretraining
values within one week but also increased 5 mmHg above pretraining values. DBP values
remained lower than pretraining values for the first week. By the end of the second week
of detraining, DBP values not only returned back to pretraining but also increased 3
mmHg above pretraining values.
In summary, the BP adaptations to exercise appear and disappear rapidly. BP
reductions are seen within one week of the onset of exercise and persist with continued
exercise training, however, BP returns to pretraining values after the cessation of exercise
within one week. However 25% of the population does not lower BP with exercise for
reasons that are unclear. In addition it is imperative to continue to exercise, even in
individuals who do not respond to exercise training, to maintain the many health benefits
associated with regular exercise including lowering BP or preventing preHTN developing
into HTN.
The Metabolic Syndrome
Background
The ATP III defines the MetS as having three or more of the following: fasting
triglycerides ≥150 mg/dL, BP ≥130/85 mmHg, fasting glucose ≥100 mg/dL, waist
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circumference for men ≥102 cm and ≥88 cm for women, and fasting high density
lipoprotein <40 mg/dL for men and <50 mg/dL for women (ATP III) (6). Although the
cause of the MetS remains unclear, many consider the most prominent underlying
contributors to be abdominal obesity and insulin resistance (40). However, some consider
HTN to be the most important contributor to the MetS because of the increased risk for
obesity and insulin resistance associated with HTN (31,32). For individuals with HTN,
65-75% of are obese and 50% are insulin resistant (33,34). Furthermore, 85% of the
individuals with the MetS have HTN (32).
Metabolic Syndrome and Blood Pressure
Ishizaka et al. (36) analyzed cross-sectional data of 8144 apparently healthy men
and women (19-88 yr) from a general health screening. Of this sample, 19% of the men
and 7% of the women were diagnosed with the MetS based on the criterion from ATP III.
Among the five metabolic risk factors, HTN was the most observed in individuals with
the MetS; 85% of men and 87% of women having HTN. The authors concluded that BP
control is important in reducing the risk for the MetS among healthy individuals.
The prevalence of the MetS doubles in individuals with preHTN when compared
to individuals with normal BP (37,38). Onat et al. (37) prospectively examined 1501 men
and 1533 women of middle age (mean age= 48 yr) with normal BP (n=978), preHTN
(n=996), and HTN (n=1060) to predict the concurrent development of HTN and the
MetS. At baseline 39.9% of men and 40.7% of women were identified as having the
MetS and an additional 454 individuals developed MetS after 6.6 yr follow up. Further,
317 individuals with normal BP at baseline developed preHTN (5% incidence /yr), 333
individuals with preHTN developed HTN (4.5% incidence/yr), and 133 individuals with
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normal BP developed HTN (1.9% incidence/yr). The authors concluded that having
preHTN doubled the risk for developing the MetS compared to having optimal BP.
Furthermore, Kanauchi et al. (38) examined the relationship between resting BP levels
and the prevalence of the MetS among apparently healthy men and women with optimal
BP, preHTN or HTN. As resting BP increased, the number of MetS components
increased, 9.9% for normal BP, 19.2% for preHTN, and 35.5% for HTN. They concluded
as baseline BP increase so does the number of components of the MetS suggesting HTN
may be an etiologic agent of the MetS (39).
There is a link between high baseline BP and the increase risk for HTN with HTN
being one of the major components that can contribute to the MetS (40). Aerobic training
has shown to be an efficient mode of exercise to reduce BP while simultaneously
improving and addressing other components associated with the MetS (41). HTN can be
a contributor in the MetS through the pathway of obesity and insulin resistance with a
hyperactivity of the sympathetic nervous system (Figure 1) (51,52,56).
Hypertension: An etiologic agent of the Metabolic Syndrome
Mechanisms
HTN affects 40% of individuals with the MetS (50). Additionally, individuals
with HTN have an increased risk of obesity and/or insulin resistance. Approximately 6575% of individuals with HTN are obese, while 50% of individuals with HTN are insulin
resistant (32,33). The kidneys, a vital organ in BP regulation, help with maintenance and
regulation of sodium and fluid homeostasis (33). Disturbance of regular kidney function
may result in development of HTN with further complications that are associated with the
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MetS (i.e., visceral adiposity and/or insulin resistance). Therefore, HTN may be an
important contributor in the etiologic agent of the MetS.
Renin Angiotensin System and Blood Pressure
The renin angiotensin system (RAS) is an important regulator of blood volume
and systemic vascular resistance. Further, the RAS is an important mechanism in BP
control and may partially explain how HTN can be a contributor in the MetS. The RAS
pathway is involved with sodium and water retention that increases blood volume and
inhibits the release of renin in the blood. Renin then acts on angiotensinogen, secreted
from the liver, to form angiotensin I. Angiotensin converting enzyme converts
angiotensin I into angiotensin II, a vasopressor. Angiotensin II has physiological effects
on the kidney as well as the adrenal cortex, vascular smooth muscle, and the brain (51).
Stimulation of angiotensin II may lead to short term functional changes including an
increase in sympathetic activity, tubular reabsorption causing water retention, the release
of aldosterone which acts on the kidneys to increase sodium and fluid retention, secretion
of antidiuretic hormone from the pituitary gland leading to an increase in kidney fluid
retention, and last, constriction of the arteriole vessels (50). These short-term adaptations
lead to an increase in blood volume, vasoconstriction of the blood vessels, and an
increase in BP (Figure 1) (51,52,56).
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Insulin and Blood Pressure
Insulin is an important hormone in glucose and lipid metabolism and in the
maintenance of endothelial function. In a healthy individual insulin (≥5-20 pmol/L)
signals to insulin receptor substrate-1 which increases activation of phosphatidylinositol3 kinase (PI-3K) leading to phosphorylation and activation of pyruvate dehydrogenase
kinase isozyme 1 (PDK-1), which then phosphorylates the activation of protein kinase B
(Akt/PKB). Akt phosphorylates nitric oxide synthase-3 (NOS3) resulting in increased
activity of NOS3 and production of nitric oxide (NO), a vasodilator that improves
endothelial function and positively influences BP. Additionally in healthy individuals
insulin stimulates production of endothelin-1 (ET-1) and NO from endothelial cells. ET-1
binds to a receptor located in smooth muscle tissue of blood vessels, endothelial type A,
which leads to constriction of the vascular smooth muscle cells. Further, ET-1 binds to
endothelial type B receptor, found on endothelial cells that release NO which inhibits ET1 action on vascular smooth muscles cells resulting in vasodilation. However, in
individuals with elevated level of insulin, an increase in insulin blocks the endothelial
type B receptor inhibiting NO from being released causing vasoconstriction of the blood
vessels (Figure 2) (57).
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Figure 2. Insulin Pathway
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Additionally, angiotensin II can also inhibit the vasodilator effects of insulin on
blood vessels causing a decrease of NO in the endothelial cells. Inhibiting insulin
signaling on the PI-3K pathway results in vasoconstriction in the smooth muscle cells.
Subsequently causing vasoconstriction of the arterioles resulting in an increase in BP
(HTN). Angiotensin II also inhibits glucose uptake into skeletal and fat muscles by
blocking GLUT-4 translocation, a transporter of glucose primarily found in adipose tissue
and skeletal muscles (52,53). The effect of angiotensin II inhibiting insulin and glucose
uptake leads to insulin resistance and/or visceral adiposity (52,50). Therefore, inhibiting
insulin on the insulin signaling PI-3K pathway may lead to impaired vascular function
(i.e., endothelial dysfunction).
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As previously stated, the activation of the RAS including Angiotensin II
stimulates and increases sympathetic nervous activity resulting in various short term
functional changes and subsequently contributing to an increase in BP (HTN). Further,
impairment of the PI-3K signaling in the endothelium may cause an imbalance with NO
production and ET-1 secretion (vasoconstriction) further leading to a decrease in blood
flow and an increase in BP (58). Additionally, HTN causes vasoconstriction and
structural changes of the blood vessels reducing the ability of arteries to vasodilate.
Together these factors contribute to an increased risk of insulin resistance and visceral
adiposity thus being a possible explanation for HTN being an etiologic agent in the MetS.
Last, adiponectin is a hormone secreted by adipocytes that regulates metabolism
of lipids, glucose and vascular function (54). Further adiponectin demonstrates protection
properties on blood vessels and anti-inflammatory properties in the endothelium by
altering NO levels (55). In healthy individuals, adiponectin demonstrates similar
characteristics to insulin by promoting glucose uptake and stimulation of NO production
in the endothelium (56,54). Like insulin, adiponectin is dependent on the activation of the
PI-3K pathway and PDK-1 that directly stimulates phosphorylation of Akt.
Phosphorylation of Akt then activates endothelial nitric oxide synthase resulting in
increase production of NO. In healthy individuals plasma adiponectin remains high,
however, low levels are negatively associated with visceral adiposity, insulin resistance,
and endothelial dysfunction (51) and can further lead to an increase in BP (54). HTN can
lead to inhibition of adponectin along with removal of glucose in skeletal and muscle
cells that may result in insulin resistance and/or an increase in adiposity (51). In
conclusion, adiponectin and insulin demonstrate similar vascular functions and increase
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the development of insulin resistance and/or adiposity. Additionally the PI-3K signaling
pathway is necessary for production of NO in the endothelium and may be a possible
mechanism to HTN being the etiologic agent of the MetS.
Regardless if it is an etiologic agent or an associated factor of the MetS, exercise
is recommended to prevent, treat and control BP as well as improve other components of
the MetS ultimately reducing the risk of acquiring CVD and Type 2 diabetes mellitus
(42,43). Bateman et al. (41) examined 234 sedentary and overweight men and women
(18-70 yr) with mild to moderate dyslipidemia in the STRRIDE study. Individuals were
randomized into one of three exercise groups; aerobic (65-80% VO2peak), resistance
training (3 d·wk-1, 3 sets of 8-12 reps), or concurrent (same exercise protocol for aerobic
and resistance training). A continuous score using the five MetS variables based on the
ATP III criteria were used to formulate the MetS z-score allowing to show improvements
in components of the MetS. After 6 months of training, the participants in the resistance
training group did not improve the parameters of the MetS or the MetS z-score
(0.13±1.76), whereas aerobic exercise training showed improvements in the MetS z-score
(-0.76±2.20) and an even more significant improvement noted in the concurrent exercise
group (-1.10±1.70), however aerobic training improved the MetS more than the
resistance training did. Thus aerobic training has shown to be an efficient mode of
exercise to reduce BP while simultaneously improving other components associated with
the MetS. However, reasons for the differences among the exercise groups was not clear,
although, Bateman et al. (41) speculated that the improvements in the MetS z-score from
the concurrent group were attributed to exercising longer, almost twice as much as those
in the aerobic or resistance group alone.
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Katzmarzyk et al. (44) examined 621 apparently healthy sedentary men and
women (17-65 yr) from the HERITAGE study. At baseline 105 (16.9%) of the 621
individuals had the MetS. After 20 wk of aerobic exercise training preformed three
times/wk at 55-75% VO2max on a cycle ergometer, 32 (30.5%) participants became free of
the MetS. These results showed the effects of exercise training reduce and prevent future
development of the MetS.
In summary, HTN is the most important contributor to the MetS and is present in
up to 85% of individuals with the MetS (32). As an initial lifestyle modification,
endurance exercise is an efficacious treatment for mild to moderate HTN additionally
reducing the risk of developing or reducing the components of the MetS.
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Chapter 3 - Methods
STRRIDE Overview
This is a sub-study of the Studies of a Targeted Risk Reduction Intervention
through Defined Exercise or STRRIDE-AT/RT (1R01HL57354; 2003-2008;
NCT00275145) (18). The two primary purposes of STRRIDE were to: 1) investigate the
effects of different types and intensities of exercise training regimens on established CVD
risk factors; and 2) to study the peripheral biologic mechanisms through which exercise
training altered these CVD risk factors. In addition, researchers also obtained pre- and
post anthropometric measurements, cardiometabolic biomarkers, and BP following 6
months of exercise training and after a 2 wk detraining (18).
Sub-Study Overview
Subjects
Volunteers were STRRIDE-AT/RT participants recruited through the local
newspaper, the Internet and word of mouth in Durham, Greenville and other surrounding
communities in North Carolina. Subjects included men and women 18-70 yr who were
exercising ≤2 d/wk or had a peak oxygen uptake (VO2peak) of ≤35 mL·kg-1·min-1. Study
inclusion criteria were: (a) body mass index (BMI) 25-35 kg·m-2; (b) resting SBP <160
mmHg and/or DBP <90 mmHg; and (c) fasting low density lipoprotein (LDL) 130-190
mg·dL-1; or fasting high density lipoprotein-cholesterol (HDL) for men ≤40 mg·dL-1 and
women ≤45 mg·dL-1. Subjects had no known metabolic, muscular, or coronary heart
disease(s) and were not taking any antilipidemic or antihypertensive medications.
Additionally, they were willing to be randomized to one of three exercise groups. Prior to
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participating in the study, individuals were screened by telephone and signed a written
informed consent approved by the IRB of the participating institutions.
Procedures
Study Design Overview. Figure1.
This STRRIDE-AT/RT sub-study was conducted to investigate the BP response
before and after 6 months of exercise training followed by 2 wk of detraining among
middle aged, sedentary adults with preHTN and mild-to-moderate dyslipidemia. The
institutional review boards of Duke University Medical Center and East Carolina
University approved the experimental design of STRRIDE-AT/RT, which has been
described in detail elsewhere (18). Only the methods used in this sub-study are described
in detail below.
Baseline Assessment

Randomization

ATvigorous

RT

AT/RT

N=34

N=28

N=13

2 Month Run in Period

6 Month Assessment

2 Wk Post Last Exercise Bout Assessment
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Figure 1. Overview of STRRIDE study. ATvigorous = Aerobic training vigorous intensity
(65-80% VO2peak); RT = Resistance training (70-85% of one repetition maximum);
AT/RT = Aerobic training and resistance training combined.
Subjects attended a baseline assessment prior to the start of the 6 month exercise
training intervention where they completed a health screening questionnaire and a series
of health fitness and anthropometric measurements including resting BP (mmHg), height
(cm), weight (kg), and waist circumference (WC). Height and weight were used to
calculate BMI (kg·m2). Fasting plasma samples was obtained to determine HDLcholesterol, triglycerides, and glucose. A cardiopulmonary exercise test (CPET) with a
12-lead electrocardiogram was used to determine VO2peak (mg·kg-1·min-1) and the
exercise intensity of the aerobic exercise training program. Pre exercise measurements
were performed at the completion of the 10 wk run in period, and again following the 6
month exercise training intervention and 2 wk detraining period.
Following baseline assessments, subjects were randomized into one of three
exercise groups: aerobic vigorous intensity (ATvigorous) (n=34), resistance training (RT)
(n=28), or aerobic exercise and resistance training combined (AT/RT) (n=13). Subject
randomization was performed using a standard computer based block design. Last,
subjects had to have obtained BP measurements pre 6 months exercise training, post 6
months exercise training, and after 2 wk detraining period.
Exercise Training Intervention
Aerobic Training Vigorous [ATvigorous (n=34)] group performed a CPET after the
run in period to ensure the appropriate exercise training intensity was maintained as
cardiorespiratory fitness increased. Subjects exercised 3 d·wk-1 at 65-80% VO2peak on
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average 130±22.7 min·wk-1 expending the caloric equivalent to walking or jogging 20
miles per wk. To ensure attainment of the proper aerobic training intensity, subjects wore
a heart rate monitor (Polar Electro, Inc., Woodbury, NY) at each session that was
uploaded weekly. Subjects were instructed to use the treadmill as the primary mode of
training, however the bicycle ergometer, elliptical, and stair climber were other modality
choices
Resistance Training [RT (n=28)] group also began with a run in period, and then one
set for the first 2 wk followed by two sets during wk three and four until they reached the
intended three sets during wk five. Subjects trained at 70-85% of their one repetition
maximum 3 d·wk-1.
Subjects used Cybex weight machines (Cybex International Inc; Medway, MA) to
perform three sets of 8-12 repetitions of eight exercises (four upper and four lower)
targeting major muscle groups. The Duke RT group used only Cybex machines while
East Carolina University used Cybex weight machines to perform lower body exercises,
abdominal crunch exercises were incorporated and at wk 14 transitioned to free weights
for upper body exercises. Subjects able to perform three sets of 12 repetitions in two
consecutive sessions increased resistance in five pound increments.
Aerobic + Resistance Training [AT&RT (n=13)] group performed the identical
training program of the aerobic and resistance training groups in combination.
Exercise Supervision
To ensure safety and adherence both sites closely monitored all training sessions.
East Carolina University provided direct supervision while Duke had direct supervision
and/or FitLinxx Strength Training Partner™ (FitLinxx; Norwalk, CT). FitLinxx Strength
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Training Partner™ is a computer system designed to electronically track workouts and
automatically send training results to the FitLinxx server.
Anthropometric Assessments
Height was measured to the nearest quarter cm and weight to the nearest 0.1 kg on
a digital scale (Scale 5005; Scale Tronix Inc, Wheaton, IL) to determine BMI (kg·m2).
WC measurements were taken around the abdominal waist at the iliac crest. Each
measurement was taken twice to the nearest 0.1 cm and averaged.
Blood Pressure
A trained research nurse measured BP by auscultation on the non-dominant arm
following standard procedures (WelchAllyn; Skaneateles Falls, NY)(Pickering et al.,
2005). Subjects sat quietly in the laboratory for 60 min with feet flat on the floor in the
relaxed position. Two BP measurements were obtained 20-30 min apart and then
averaged by a nurse trained in standard procedures (45). Mean arterial pressure (MAP)
was determined by: DBP + 0.33* (SBP-DBP).
Fasting Blood Determinations
Lipids and Lipoproteins
HDL cholesterol and triglycerides were analyzed from fasting plasma using
nuclear magnetic resonance (LipoScience; Raliegh, NC).
Glucose
Subjects fasted 12 hr only consuming water during this time. Fasting plasma
samples were used to determine glucose by nuclear magnetic resonance (LipoScience;
Raliegh, NC).
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Metabolic Syndrome Classification
The MetS was defined as having three or more of the following: triglycerides
≥150 mg/dL, BP ≥ 130/85 mmHg, fasting glucose ≥100 mg/dL, WC for men ≥102 cm
and women ≥ 88 cm, and/or high fasting density lipoprotein <40 mg/dL for men and
women <50 mg/dL (JAMA, 2001). Last, the MetS components were used to calculate the
MetS z-score.
Metabolic Syndrome z-score
The MetS z-score was a continuous standardized calculation of the five MetS
components: HDL-cholesterol, triglycerides (TG), fasting blood glucose (FBG), WC, and
MAP The MetS z-score enabled the five MetS components with different scales to be
compared. Individual subject data, current ATP III criteria, and standard deviations from
the entire STRRIDE AT/RT cohort at baseline were used to calculate the MetS z-score.
The MetS z-score equations used separate standard deviations for men and women,
specifically for HDL-cholesterol and WC.
The equations used to calculate the MetS z-score were as follows:{z-Score = [(40HDL)/6.2] + [(TG-150)/66.2] + [(FBG-100)/10.4] + [(WC-102)/9.3] + [(MAP-100)/8.7]}
for men and {z-Score = [(50-HDL)/11.8] + [(TG-150)/66.2] + [(FBG-100)/10.4] + [(WC88)/9.2] + [(MAP-100)/8.7]} for women (Bateman et al., 2011).
Cardiopulmonary Graded Exercise Test
The CPET was completed for individuals in the aerobic group after the run in
period and after completion of 6 months of exercise training. The test was performed on a
treadmill with a 12-lead electrocardiograph and expired gas analysis using a TrueMax
2400 Metabolic Cart (ParvoMEdics; Sandy, UT). The test protocol included two min
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stages with the workload increasing by one metabolic equivalent per stage. VO2peak
(mg·kg-1·min-1) was determined by averaging the two consecutive highest 15 second
readings. A respiratory exchange ratio ≥ 1.10 was the criteria used to terminate the test.
Muscle Strength Evaluation
Total amount of weight lifted in kilograms during a single session during wk 5
was used to calculate muscle strength for baseline measurements. At wk 32 the same
measurements were used for end of the training measurements. Total amount weight
lifted was determined by accumulation of weight, number of repetitions multiplied by
number of sets.
Statistical Analysis
Descriptive statistics (mean±SD) were calculated for all sub-study variables.
Repeated measures analysis of covariance (ANCOVA) was used to test the change in BP
before versus after training and over 2 wk of detraining (i.e., after training versus after 2
wk of detraining) and within and between training groups (ATvigorous, RT, and AT/ RT).
Gender was used as a fixed factor and baseline BMI, MetS z-score, and VO2peak were
used as covariates. Chi-Square was used to test the frequencies of individuals who
decreased (i.e., responders) or increased (i.e., non-responders) BP before versus after
exercise training and after training versus after detraining. The median, zero, was used as
the cut point to determine responder (changes less than zero) and non responder (changes
greater than or equal to zero). A linear and multivariable regression was performed to
explore subject characteristics and the BP response to detraining as predictors of the BP
response to exercise training. In addition, the variance inflation factor (VIF) less than 3
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was used to determine there was no collinearity among the various independent variables
used in the multivariable regression models.
Last, to examine the inter and intra variability in the response to CVD risk factors
to exercise training, a chi-square was used to test the frequencies of those individuals
who decreased (i.e., responders) and increased (i.e., non-responders) the sum of the
response of the individual components of the cardiometabolic profile before versus after
exercise training. The sum of the cardiometabolic profile was determined by assigning 1
as a favorable change and -1 as an unfavorable change for the following components:
BMI, WC, fasting glucose, triglycerides, VO2peak, and BP (mmHg). The median, zero,
was used as the cut point to determine favorable (changes less than zero) and unfavorable
changes (changes greater than or equal to zero). Statistical Package for Social Science
(SPSS) version 19.0 for Macintosh (IBM, Armok, NY) with p<0.005 was used as the
level of statistical significance.
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Chapter 4 - Results
Descriptive Characteristics
Subject Characteristics
The sub-study population consisted of 75 sedentary, middle aged, overweight men
and women with mild to moderate dyslipidemia and PreHTN (Table 1). Exercise SBP
responders had a higher BMI (p=0.025) and resting BP (p=0.003) and lower glucose
levels (p=0.031) and VO2peak (p=0.051) than exercise non-responders. Exercise DBP
responders had a higher resting BP compared to DBP non-responders (p=0.025). All
other characteristics were not different between exercise SBP and DBP responders and
non-responders (p>0.05).
Blood Pressure Response to Exercise Training and Detraining among the Total
Sample and by Modality
The change in SBP/DBP of 0.4±10.6/-0.8±7.0 mmHg pre to post 6 months of
exercise training was not different among the total sample (p>0.05). In addition, the
change in SBP/DBP pre to post 6 months of exercise training was not different by
modality, i.e., 1.9±10.8/0.1±6.0 mmHg for ATvigorous (n=34), 2.5±8.3/-0.8±5.5 mmHg for
RT (n=28), and -4.0±10.1/-2.4±9.1 mmHg for AT/RT (n=13) (p>0.05).
The change in SBP/DBP of 0.3±11.7/0.9±8.7 mmHg after 2 wk of detraining was
not different among the total sample (p>0.05). In addition, the change in SBP/DBP
following 2 wk of detraining was not different by modality, i.e., -1.4±11.0/-2.3±8.2
mmHg for ATvigorous (n=34), -0.6±10.2/1.4±7.8 mmHg for RT (n=28), and
3.1±11.3/3.9±8.3 mmHg for AT/RT (n=13) (p>0.05).
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The change in VO2peak mL·kg-1·min-1 pre to post 6 months of exercise training was
not different among the total sample (p>0.05). In addition, the change in VO2peak pre to
post 6 months of exercise training was not different by modality, i.e., 1.9±10.8/0.1±6.1
mL·kg-1·min-1 for ATvigorous (n=34), 2.5±8.2 mL·kg-1·min-1 for RT (n=28), and -4.2±9.8/2.5±9.5 mL·kg-1·min-1 for AT/RT (n=13) (P>0.05).
Blood Pressure Response to Exercise Training and Detraining among Responders and
Non-Responders
Exercise training responders decreased SBP 10.0±6.7 (n=19) and DBP 9.1±4.9
(n=25); whereas exercise training non-responders increased SBP 9.6±7.6 (n=28) and
DBP 6.2±5.3 (n=26) pre to post 6 months of exercise training (p<0.001). Furthermore,
the SBP (p<0.001) /DBP (p<0.001) change pre to post 6 months of exercise training was
different between responders and non-responders (p<0.001). In addition, exercise
detraining responders decreased SBP 9.1± 5.4 (n=28) and DBP 7.4± 5.0 (n=26); whereas
exercise detraining non-responders increased SBP 12.4± 8.4 (n=19) and DBP 7.0±8.4
(n=25) at the conclusion of exercise training followed by 2 wk of detraining (p<0.001).
Additionally, the SBP/DBP change at the conclusion of exercise training followed by 2
wk of detraining was different between responders and non-responders (p<0.001).
Of the 29 people that decreased SBP with training (i.e., responders), 65.5% increased
SBP with detraining; however, 34.5% decreased SBP with detraining. In addition, of the
46 people that increased SBP with training (i.e., non-responders), 48.6% increased SBP
with detraining, while 73.7% decreased SBP with detraining (p=0.034). Similar trends
were found with DBP. Of the 34 people that decreased DBP with training (i.e.,
responders), 80.6% increased DBP with detraining; whereas 19.4% decreased DBP with
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detraining. Of the 44 people that increased DBP with training (i.e., non-responders),
41.9% increased DBP with detraining; while 81.3% decreased DBP with detraining
(p=0.001).
Predictors of Blood Pressure with Exercise Training
Table 2 displays the multivariate regression predictors of the BP response pre to
post 6 months of exercise training. Factors accounting for 44.8% of the variance in SBP
were pretraining SBP, the SBP response to detraining, and the change in the MetS z-score
pre to post 6 months of exercise training (p<0.001). Factors accounting for 60.1% of the
variance in the DBP to exercise training were the pretraining DBP, the DBP response to
detraining, and the change in the MetS score pre to post 6 months of exercise training
(p<0.001).
Comparison of the Blood Pressure and Cardiometabolic Profile Response to Exercise
Training
There were no differences exhibited in the BP response pre to post 6 months of
exercise training and the sum of individual components response of the cardiometabolic
profile and the MetS z-score to exercise training for the total sample (p>0.05). Exercise
SBP and DBP responders improved the MetS z-score pre to post 6 months of exercise
training (p<0.001), and this response did not improve for SBP and DBP non-responders
(p<0.001). All other components of the cardiometabolic profile were not different
between exercise SBP and DBP responders and non-responders pre to post 6 months of
training (p>0.05).
Among the 29 people that decreased SBP with exercise training (i.e., responders),
30.0% increased the sum of the individual components of the cardiometabolic profile
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with exercise training indicating an unfavorable response, while 48.6% were found to
decrease the sum of the individual components of the cardiometabolic profile indicating a
favorable response pre to post 6 months of exercise training. In addition, of the 46 people
that increased SBP with exercise training (i.e., non-responders), 60.9% increased the sum
of the individual components of the cardiometabolic profile, while 39.1% decreased the
sum of the individual components of the cardiometabolic profile pre to post 6 months of
exercise training (p=0.079).
Similar trends were found with DBP. Among the 31 that decreased DBP with
exercise training (i.e., responders), 31.0% increased the sum of the individual
components of the cardiometabolic profile with exercise training (i.e., non-responders),
while 54.5% decreased the sum of the individual components of the cardiometabolic
profile pre to post 6 months of exercise training. Of the 44 that increased DBP with
exercise training, 65.9% increased the sum of the individual components of the
cardiometabolic profile with exercise training (i.e., non-responders), while 34.1% were
found to decrease the sum of the individual components of the cardiometabolic profile
pre to post 6 months of exercise training (p=0.034).
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Table 1. Pretraining Subject Characteristics (Mean±SD) of the Total Sample and by Those Who
Decreased Blood Pressure After Exercise Training (Responders) and Those Who Did Not
(Non-Responders)
DBP

SBP

Variable

Total Sample
(n=75)

Responder
(n=29)

Non
responder
(n=46)

Responder
(n=31)

Non
responder
(n=44)

Age (yr)

50.2±10.6

52.6±12.0

48.7±9.5

50.2±11.0

50.3±10.4

SBP (mmHg)

120.0±13.7

125.8±14.3**

116.3±12.0

121.7±15.9

118.7±11.9

DBP (mmHg)

79.1±9.2

80.7±9.7

78.1±8.8

81.9±9.7*

77.1±8.4

BMI (kg/m2)

30.5±3.2

31.5±2.7*

29.8±3.3

30.3±2.9

30.6±3.3

WC (cm)

97.0±9.8

97.3±9.8

96.7±9.9

97.5±10.0

96.5±9.7

CHOL (mg·dL1)

226.2±31.6

228.7±36.8

224.6±28.2

228.6±31.4

224.5±31.9

HDL (mg·dL-1)

52.1±15.0

55.2±14.6

50.2±15.1

51.8±16.6

52.4±13.9

LDL (mg·dL-1)

144.2±25.1

143.4±30.5

144.8±21.3

143.9±26.

144.4±24.6

TG (mg·dL-1)

153.3±85.7

150.0±68.6

155.4±95.5

171.8±101.2

140.3±71.2

Glucose (mg·dL-1)

92.4±11.5

88.8±13.9*

94.7±9.1

89.9±14.3

94.3±8.8

8.9±4.5

9.2±5.7

8.7±3.6

8.5±4.6

9.3±4.5

Insulin (mg·dL1)

VO2peak
(mL·kg-1·min-1)
28.1±6.5
29.3±6.8
29.8±6.9
27.0±6.0
26.3±5.6*
SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; BMI, Body Mass Index; WC, Waist
Circumference; CHOL, Cholesterol; HDL, High Density Lipoprotein; LDL, Low-Density
Lipoprotein; VO2peak, Peak Oxygen Uptake; Metabolic Syndrome Score;{z-Score = [(40-HDL)/6.2]
+ [(TG-150)/66.2] + [(FBG-100)/10.4] + [(WC-102)/9.3] + [(MAP-100)/8.7]} for men and {z-Score
= [(50-HDL)/11.8] + [(TG-150)/66.2] + [(FBG-100)/10.4] + [(WC-88)/9.2] + [(MAP-100)/8.7]} for
women; Responder vs Non Responder *p<.05, ** p<.001
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Table 2. Multivariable Regression Predictors of the Blood Pressure Change Pre to Post 6
Months of Exercise Training among STRRIDE Participants (n=75)
Exercise Training
Blood Pressure

Predictors

r2

β

t

Partial r

-.461

-5.149

-.521

<.001

-.379

-4.171

-.444

<.001

.235

2.536

.288

.013

.686

.448 <.001

p

Change
Systolic Blood

Change Detraining Systolic

Pressure

Blood Pressure
Pretraining Systolic Blood
Pressure
Metabolic Syndrome Z-Score

Model Summary
Diastolic Blood

Change Detraining Diastolic

Pressure

Blood Pressure
Pretraining Diastolic Blood
Pressure
Metabolic Syndrome Z-Score

Model Summary
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-.448

-5.595

-.553

<.001

-.339

-4.245

-.450

<.001

.371

4.405

.463

<.001

.786

.601 <.001

Table 3. The Change (Mean±SD) in the Individual Components of the Cardiometabolic
Profile and the Metabolic Syndrome Z Score of the Total Sample and by Those Who
Decreased (Responder) and Increased (Non Responder) BP Pre to Post 6 Months of
Exercise Training.
DBP

SBP
Cardiometabolic

Total

Profile

Sample

Component

(n=75)

BMI (kg/m2)

-0.6±3.1

-0.1±0.8

-1.0±3.9

-0.5±1.1

-0.7±4.0

WC (cm)

-1.1±3.5

-0.3±2.7

-1.6±3.8

-2.0±3.9

-0.4±3.1

TG (mg·dL-1)

-18.1±54.4

-25.1±53.5

-13.7±61.5

-32.2±61.0

-8.2±55.1

GLU (mg·dL-1)

0.4±9.1

0.02±8.5

0.7±9.6

0.01±9.1

0.7±9.2

Metabolic
Syndrome Score

-0.5±2.0

-1.4±1.6** §

0.06±2.1

-1.6±2.1**§

0.3±1.6

Responder

Non

Responder

Non

(n=29)

Responder

(n=31)

Responder

(n=46)

(n=44)

**p<0.001 Responder vs Non Responder, §p<0.001 pre to post exercise training
STRRIDE, Studies of a Targeted Risk Reduction Intervention through Defined Exercise
BMI, Body Mass Index; WC, Waist Circumference; TG, Triglycerides ; GLU, Glucose;
SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; Metabolic Syndrome
Score; :{z-Score = [(40-HDL)/6.2] + [(TG-150)/66.2] + [(FBG-100)/10.4] + [(WC102)/9.3] + [(MAP-100)/8.7]} for men and {z-Score = [(50-HDL)/11.8] + [(TG150)/66.2] + [(FBG-100)/10.4] + [(WC-88)/9.2] + [(MAP-100)/8.7]} for women

35

Chapter 5 - Discussion
The purpose of this STRRIDE-AT/RT sub-study was to examine the BP response
after 6 months of exercise training followed by a 2 wk detraining period among middle
aged, sedentary men and women with preHTN and mild to moderate dyslipidemia. The
major findings of this STRRIDE-AT/RT sub-study were there was no difference in BP
before versus after exercise training and following 2 wk detraining among the total
sample, regardless of modality. However, the change in BP after 6 months of exercise
training was significantly and negatively correlated with the change in SBP (r= -0.474)
and DBP (r= -0.540) after 2 wk detraining. Approximately one third of STRRIDEAT/RT participants decreased BP with exercise training and increased BP with
detraining. However, contrary to our hypothesis, over one third of STRRIDE-AT/RT
participants increased BP with exercise training and decreased BP with detraining.
Additionally the major predictors of the SBP/DBP response to training were the
BP response to detraining (r= -0.521/-0.553), pretraining BP (r= -0.444/-0.450), and
number of MetS components (r=0.288/0.463), which overall accounted for 44.8%/60.1%
of the variability in the SBP/DBP response to exercise training, respectively. It is of
interest to note that although the number of components of the MetS accounted for
8%/21% of the SBP and DBP response to exercise training, there was variability in the
response of the various components of the cardiometabolic profile to exercise training.
Approximately one third of the participants that decreased BP experienced an
unfavorable change in the overall cardiometabolic profile following exercise training;
whereas another one third of the participants that increased BP experienced a favorable
change in the overall cardiometabolic profile following exercise training.
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The results of this sub-study provide novel findings demonstrating middle aged,
sedentary, men and women with preHTN may not respond to the antihypertensive effects
of exercise but rather respond to the antihypertensive effects of detraining. Furthermore,
the BP response to exercise training does not necessarily align with the response of the
other components of the cardiometabolic profile to exercise training. Reasons are unclear
as to why some individuals experience an adverse BP response to exercise training,
however, our findings are consistent with the reports of others that approximately 25% of
people do not lower there BP as a result of exercise training (46,15), and the mean BP
response is often exceeded by the SD of the response (13). Most recently, Bouchard et
al. (23) consolidated the findings from six of the largest exercise training studies
conducted to date that include STRRIDE and found 12.2% of the STRRIDE-AT/RT substudy participants experienced an adverse SBP response to exercise training. In addition,
these authors found the BP response to exercise training was not only variable among
individuals, but the response of the various components of the cardiometabolic profile is
quite variable both within an individual and among individuals (23). For someone who
experiences an adverse BP response to exercise training, may not experience an adverse
response of other components of the cardiometabolic profile to exercise training.
Our findings and those of Bouchard (13,23) suggest that eventually health care
professionals may identify which individuals respond and do not respond to exercise
training as antihypertensive therapy by obtaining a baseline cardiometabolic profile.
Further, clinicians may be able to use baseline predictors (i.e., BP, MetS z-score) to
identify individuals at risk for an adverse response to exercise and provide an alternative
treatment approach for their high BP.
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Blood Pressure Response to Exercise Training and Detraining
As hypothesized the SBP (r= -0.474) and DBP (r= -0.540) response to training
and detraining was negatively correlated (p<0.01). This finding supports our hypothesis
and is consistent with the existent literature. Meredith et al. (16) found individuals with
optimal BP exercising 3-4 d·wk-1 on a bicycle ergometer at 60-70% VO2max exhibited BP
reductions of 8mmHg for SBP and 5mmHg for DBP) after one month of the onset of
exercise training. However, after 2 wk of stopping exercise training, BP returned to
baseline values. Similarly, Murray et al. (17) reported men with optimal BP exercising 30
min·d-1 at 60% VO2peak for one month decreased SBP 10 mmHg and DBP 8 mmHg.
Within 1 wk after the cessation of exercise SBP increased 5mmHg and DBP 3mmHg and
regressed to baseline values. The findings of Meredith et al. (16) and Murray et al. (17)
further support the notion that exercise training needs to continue for the antihypertensive
benefits of exercise to persist, and these benefits rapidly diminish with the cessation of
exercise training.
However, what was unexpected is that we found 65.5%/73.7% (SBP/DBP
respectively) of STRRIDE participants responded to the antihypertensive effects of
exercise training where as 80.6%/81.3% (SBP/DBP respectively) responded to the
antihypertensive effects of detraining. Although it is generally thought that BP decreases
with exercise training and returns to baseline values with detraining, there is growing
evidence of documenting the considerably variability that exists of the response of health
related phenotypes to exercise (13,46). Although reasons for this variability remain
unclear, identifying clinical characteristics accounting for this variability provides
important insight that should be investigated further.
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Predictors of Blood Pressure Response to Exercise Training
Reasons for the unexpected findings of BP increasing with exercise training and
decreasing with detraining in this sub-study may reside within the predictors of the BP
response to training that we found. The major predictors of the BP response to exercise
training were the BP response to detraining, pretraining BP and the MetS z-score, which
overall accounted for 44.8% and 60.1% of the variance in the SBP/DBP response to
exercise training.
These findings are in agreement with previous studies showing baseline BP and
the presence of the MetS is associated with the BP response to exercise training. Erdogen
et al. (47) examined individual progression of preHTN to HTN among 98 men and
women (30-65 yr) with the MetS and preHTN. The aim of the study was to examine the
risk of individuals developing HTN while investigating possible predictors of the change
in BP status over a 3 yr period. At enrollment 51 (52%) individuals were classified as
having the MetS (the presence of three or more risk factors), however, during the 3 yr
follow up 29 (30%) individuals developed HTN and 69 (70%) remained preHTN.
Individuals who developed HTN over the 3 yr follow up exhibited lower levels of
HDL-C, displayed higher baseline SBP and the presence of the MetS was significantly
higher at the 3 yr follow up, when compared to individuals who maintained preHTN
status. These results indicate the progression of preHTN to HTN significantly and
positively correlated with baseline SBP (p=0.002) and the presence of the MetS
(p=0.009). Furthermore, these findings lend support that baseline BP and the presence of
the MetS clinically important predictive validity regarding the progression of preHTN to
HTN among middle age individuals.
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In addition to baseline BP, the presence of the MetS may also be a predictor for
the BP response to exercise training. Ferriera et al. (48) performed a 6 yr longitudinal
study using data from apparently healthy adults in an ongoing observational study. They
examined the change in the MetS status and carotid remodeling (structural and functional
adaptations) and stiffening. At baseline individuals with persistent MetS exhibited
significantly higher interadventitial diameter lumen diameter, circumferential wall
tension and wall stress, and Young’s elastic modulus when compared to those who never
developed MetS.
Over the follow up period, individuals with persistent MetS exhibited arterial
enlargement due to greater increases in intima media thickness while the same group of
individuals displayed increases in interadventitial diameter, lumen diameter,
circumferential wall tension and wall stress, and Young’s elastic modulus as a result of
an increase in BP. Over the follow up period individuals with persistent MetS exhibited
significantly greater increases in intima media thickness and cross sectional area of
intima media thickness, interadventitial diameter, lumen diameter, and circumferential
wall tension and wall stress resulting in structural and functional adaptations (i.e.,
increase BP). Individuals with the MetS displayed increases in intima, the innermost
layer of the arterial wall made up of endothelial cells, resulting in a thicker intima causing
the lumen diameter to decrease. Further the reductions in the lumen diameter resulted in
vasoconstriction of the arteries and a reduction in blood flow.
The authors concluded that indivdiuals with persistent MetS exhibit loss of
elasticity as a result of increased interadventitial diameter, lumen diameter, and Young’s
elastic modulus a the media layer further explaining arterial enlargement. Furthermore,
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increases in interadventitial diameter and lumen diameter were related to changes in SBP
and DBP. However, changes in SBP were more strongly linked to the changes in
interadventitial diameter and lumen diameter than changes in DBP.
Limitations and Strengths
Limitations of this STRRIDE-AT/RT sub-study were the main outcome did not
intend to examine the BP response to training and detraining. The data used in this substudy were collected at two test sites: East Carolina University and Duke Center for
living. However, to ensure consistent data collection was obtained, a standardized
protocol was adhered to. The concurrent group required double the amount of time
commitment which resulted in lower adherence. Last, misclassification may have resulted
from BP measurement error (23). A strength of STRRIDE-AT/RT was that it was a
randomized control trail. To ensure proper technique and intensity, participants were
supervised at each session, and, as previously stated, a computer program on the Cybex
machines and a heart rate monitors were used to confirm adherence to the prescribed
intensity.
Conclusion/Future Directions
In this sub-study, we observed no difference in the BP response to exercise
training and detraining among the total sample, regardless of modality. However, the
change in BP after 6 months of exercise training was significantly and negatively
correlated with the change in BP after 2 wk detraining. Of the 29 people that decreased
SBP with training (i.e., responders), 65.5% increased SBP with detraining as expected. In
addition, of the 46 people that increased SBP with training (i.e., non responder), 73.7%
decreased SBP with detraining. Similar trends were found with DBP. Of the 31 people
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that decreased DBP with training, 80.6% increased DBP with detraining, while of the 44
people that increased DBP with training 81.3% decreased DBP with detraining.
Surprisingly, a third of the men and women did not respond to the antihypertensive
effects of exercise but rather responded to the antihypertensive effects of detraining.
Further the BP response to detraining, resting BP and MetS accounted for 44.8% of SBP
and 60.1% of DBP variability in the BP response to exercise training. Our findings
support the work of the HERRITAGE study suggesting considerable there is intra-and
inter-variability of the response of health related phenotypes such as BP to exercise
training. Additionally, the work of Erdogan et al. (47) suggests that the presence of the
MetS is an important predictor of the progression of preHTN to HTN. Currently there
have been no studies that have investigated the BP response to exercise training and
detraining in the same group of individuals. Further research is needed to elucidate why
some individuals decrease their BP with exercise training while others increase their BP
with exercise training.
Clinical Significance
It is of importance for clinicians to identify those baseline characteristics (i.e., BP)
that predict the response of cardiometabolic risk factors to exercise among individuals at
a greater risk for adverse response to exercise training to help reduce and prevent
incidences of cardiovascular risks.
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